{
    "organizations": [],
    "uuid": "a90a9265b946d5a69e4fbf86b2afbe88180761a7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sofinnova-partners-leads-erydels-2/brief-sofinnova-partners-leads-erydels-26-5-million-financing-idUSFWN1S102I",
    "ord_in_thread": 0,
    "title": "BRIEF-Sofinnova Partners leads Erydel’s €26.5 million financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Sofinnova Partners:\n* Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced today it has led EryDel’s €26.5 M financing\n* The Italian biotech company, which specializes in drug delivery through red blood cells, will be using funds to boost its international development and to complete the ATTEST trial - a registrational Phase III clinical trial currently enrolling in Europe, Asia, Australia and in the United States\n* Existing shareholders Genextra SpA and Innogest SGR also participated to the investment\n ",
    "published": "2018-04-24T14:07:00.000+03:00",
    "crawled": "2018-04-25T14:19:52.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "sofinnova",
        "partner",
        "sofinnova",
        "partner",
        "leading",
        "european",
        "venture",
        "capital",
        "firm",
        "specialized",
        "life",
        "science",
        "announced",
        "today",
        "led",
        "erydel",
        "financing",
        "italian",
        "biotech",
        "company",
        "specializes",
        "drug",
        "delivery",
        "red",
        "blood",
        "cell",
        "using",
        "fund",
        "boost",
        "international",
        "development",
        "complete",
        "attest",
        "trial",
        "registrational",
        "phase",
        "iii",
        "clinical",
        "trial",
        "currently",
        "enrolling",
        "europe",
        "asia",
        "australia",
        "united",
        "state",
        "existing",
        "shareholder",
        "genextra",
        "spa",
        "innogest",
        "sgr",
        "also",
        "participated",
        "investment"
    ]
}